Stock ANIK ANIKA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Anika Therapeutics, Inc.

Equities

ANIK

US0352551081

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-14 pm EDT 		5-day change 1st Jan Change
26.28 USD +1.19% Intraday chart for Anika Therapeutics, Inc. +1.90% +15.98%
May. 30 Caligan Partners Enters into a Cooperation Agreement with Anika Therapeutics CI
May. 28 Anika Therapeutics Approves $40 Million Share Repurchase Program MT

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Anika Therapeutics, Inc. Announces Board Changes
CI
Anika Therapeutics, Inc. Announces Management Changes, Effective June 3, 2024
CI
Anika Therapeutics, Inc. Announces Board Changes
CI
Anika Therapeutics, Inc. Appoints Anne Nunes as Senior Vice President, Chief Operations Officer
CI
Anika Therapeutics reaches settlement with activist investor Caligan
RE
ANIKA THERAPEUTICS SAYS IT SETTLED BOARDROOM CHALLENGE WITH CALI…
RE
Anika Therapeutics, Inc. Appoints Gary Fischetti as Class III Director
CI
Caligan pushes ahead with board challenge at Anika, nominates two directors
RE
Caligan pushes ahead with board challenge at Anika, nominates two directors
RE
Insider Buy: Anika Therapeutics
MT
Anika Appoints Sheryl Conley to Board of Directors
CI
Insider Trends: Insider Purchase of Anika Therapeutics Stock Extends 90-Day Positive Trend
MT
Insider Trends: 90-Day Insider Buying Trend at Anika Therapeutics Slowed with Sale of Shares
MT
Anika Therapeutics, Inc. Announces Board Changes
CI
Anika Therapeutics, Inc. Announces Executive Changes, Effective August 10, 2020
CI
Anika Therapeutics, Inc. Announces Resignation of Sylvia Cheung as Chief Financial Officer Effective August 21, 2020
CI
Anika Therapeutics, Inc. Announces Resignation of Sylvia Cheung as Treasurer and Assistant Secretary Effective August 21, 2020
CI
Anika Therapeutics, Inc. Appoints Cheryl R. Blanchard as President and Chief Executive Officer
CI
Anika Therapeutics, Inc. Appoints David Colleran as Executive Vice President, General Counsel and Corporate Secretary
CI
Anika Therapeutics Names Board Member Dr. Cheryl Blanchard as Interim CEO
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ANIK Stock
  4. News Anika Therapeutics, Inc.
  5. Insiders